These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 2544900)

  • 1. Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats.
    Schmidt WJ; Bubser M
    Pharmacol Biochem Behav; 1989 Mar; 32(3):621-3. PubMed ID: 2544900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of N-methyl-D-aspartate (NMDA) receptors in experimental catalepsy in rats.
    Mehta AK; Ticku MK
    Life Sci; 1990; 46(1):37-42. PubMed ID: 2153885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dizocilpine (MK-801) on the catalepsy induced by delta 9-tetrahydrocannabinol in mice.
    Kinoshita H; Hasegawa T; Katsumata Y; Kameyama T; Yamamoto I; Nabeshima T
    J Neural Transm Gen Sect; 1994; 95(2):137-43. PubMed ID: 7865168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MK 801 reverses haloperidol-induced catalepsy from both striatal and extrastriatal sites in the rat brain.
    Kaur S; Ozer H; Starr M
    Eur J Pharmacol; 1997 Aug; 332(2):153-60. PubMed ID: 9286616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptor participation in experimental catalepsy in rats.
    Verma A; Kulkarni SK
    Psychopharmacology (Berl); 1992; 109(4):477-83. PubMed ID: 1365866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine-induced catalepsy is augmented by NMDA receptor antagonists, but is partially attenuated by an AMPA receptor antagonist.
    Tzschentke TM; Schmidt WJ
    Eur J Pharmacol; 1996 Jan; 295(2-3):137-46. PubMed ID: 8720577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the NMDA receptor antagonist MK-801 against amygdaloid-kindled seizures in the rat.
    Young NA; Lewis SJ; Vajda FJ; Beart PM
    Exp Neurol; 1989 Feb; 103(2):199-202. PubMed ID: 2536332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The competitive NMDA receptor antagonist SDZ 220-581 reverses haloperidol-induced catalepsy in rats.
    McAllister KH
    Eur J Pharmacol; 1996 Oct; 314(3):307-11. PubMed ID: 8957251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional neuroprotective effects of the NMDA receptor antagonist MK-801 (dizocilpine) in hypoglycemic brain damage.
    Papagapiou MP; Auer RN
    J Cereb Blood Flow Metab; 1990 Mar; 10(2):270-6. PubMed ID: 2154510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamatergic neurotransmission mediated by NMDA receptors in the inferior colliculus can modulate haloperidol-induced catalepsy.
    Melo LL; Santos P; Medeiros P; Mello RO; Ferrari EA; Brandão ML; Maisonnette SS; Francisco A; Coimbra NC
    Brain Res; 2010 Aug; 1349():41-7. PubMed ID: 20558148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine.
    Hauber W; Andersen R
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Nov; 348(5):486-90. PubMed ID: 8114947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MK-801-induced stereotypy and its antagonism by neuroleptic drugs.
    Tiedtke PI; Bischoff C; Schmidt WJ
    J Neural Transm Gen Sect; 1990; 81(3):173-82. PubMed ID: 1975747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice.
    Carlsson M; Carlsson A
    J Neural Transm; 1989; 75(3):221-6. PubMed ID: 2538557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMDA receptor antagonists inhibit catalepsy induced by either dopamine D1 or D2 receptor antagonists.
    Moore NA; Blackman A; Awere S; Leander JD
    Eur J Pharmacol; 1993 Jun; 237(1):1-7. PubMed ID: 8359205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of N-methyl-D-aspartate (NMDA) antagonist MK-801 on breathing pattern in rats.
    Monteau R; Gauthier P; Rega P; Hilaire G
    Neurosci Lett; 1990 Feb; 109(1-2):134-9. PubMed ID: 2156189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NMDA receptor antagonist MK-801 increases morphine catalepsy and lethality.
    Trujillo KA; Akil H
    Pharmacol Biochem Behav; 1991 Mar; 38(3):673-5. PubMed ID: 1829839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of NMDA receptor subtypes in the induction of catalepsy and increase in Fos protein expression after administration of haloperidol.
    Yanahashi S; Hashimoto K; Hattori K; Yuasa S; Iyo M
    Brain Res; 2004 Jun; 1011(1):84-93. PubMed ID: 15140647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective N-methyl-D-aspartate (NMDA) antagonists increase gastric motility in the rat.
    Shinozaki H; Gotoh Y; Ishida M
    Neurosci Lett; 1990 May; 113(1):56-61. PubMed ID: 1973272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticonvulsant action of a non-competitive antagonist of NMDA receptors (MK-801) in the kindling model of epilepsy.
    Sato K; Morimoto K; Okamoto M
    Brain Res; 1988 Oct; 463(1):12-20. PubMed ID: 2848606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of NMDA antagonists in the radial arm maze task with an interposed delay.
    Butelman ER
    Pharmacol Biochem Behav; 1990 Mar; 35(3):533-6. PubMed ID: 2160086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.